Strome Group, Inc., Insider at Zivo Bioscience, Inc. (ZIVO), bought 20,000 shares at $9.77 ($195K) on 2026-02-12, disclosed to the SEC on 2026-02-17.
Open-market purchase of $195k ZIVO by Insider. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.